Katie Paul Friedman

The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency

Russell S. Thomas, Tina Bahadori, Timothy J. Buckley et al. · Toxicological Sciences · 2019 · 364 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +16

Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization

Katie Paul Friedman, Matthew Gagné, Lit‐Hsin Loo et al. · Toxicological Sciences · 2019 · 245 citations · Full text

Pharmacy, Toxicology, Environmental Toxicology +16

Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with <i>in Vitro</i> Testing and Adverse Outcome Pathway Approaches

Pamela D. Noyes, Katie Paul Friedman, Patience Browne et al. · Environmental Health Perspectives · 2019 · 194 citations · Full text

Pharmacy, Endocrinology, Toxicology +17

Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling

Johanna Nyffeler, Clinton Willis, Ryan Lougee et al. · Toxicology and Applied Pharmacology · 2019 · 144 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +16

Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries

Katie Paul Friedman, Eric D. Watt, Michael W. Hornung et al. · Toxicological Sciences · 2016 · 136 citations · Full text

Pharmacy, Biochemistry, Toxicology +10